Archive · 20 Sep 2025
Mounjaro Shows Promise in Treating Type 2 Diabetes in Youth
Imagine a medicine called Mounjaro that might help kids with a type of diabetes.
This medicine helps lower the amount of sugar in their blood, which is a good thing!
Doctors are testing it on kids as young as 10.
Right now, it's only for adults, but if it works well for kids, it could help them avoid getting very sick later on.
The number of kids with this type of diabetes is growing, so finding new ways to help them is very important.
Mounjaro, a GLP-1-based drug, has shown promise in treating type 2 diabetes in children.
The study included children as young as 10 years old.
Mounjaro was found to reduce blood sugar levels and aid weight loss.
Eli Lilly, the drug manufacturer, seeks to expand approval for younger patients.
The diagnosis rate of type 2 diabetes in children nearly doubled between 2002 and 2018.
- Who
- Children with type 2 diabetes and researchers.
- What
- A new study shows Mounjaro can significantly reduce blood sugar levels and support weight loss in children with type 2 diabetes.
- When
- The study results are recent; diagnosis rates increased between 2002-2018.
- Where
- United States.
- Why
- To address the rising rates of type 2 diabetes in children and provide more treatment options.
- Drug Name
- Mounjaro
- Focus
- Type 2 Diabetes in children
- Age Range Studied
- 10 years and older
- Key Benefit
- Reduced blood sugar & weight loss
- Manufacturer
- Eli Lilly
- Current Status
- Awaiting expanded approval for young patients